$6.94
0.182.66%
At Close: -
$6.96
0.020.29%
After Hours: Aug 23, 6:30 PM EDT
15 minutes delayed
Altimmune reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Altimmune using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.35 | $-0.34 | -2.94 % |
Mar 2024 | 2024-05-09 | $-0.34 | $-0.37 | 8.11 % |
Dec 2023 | 2024-03-27 | $-0.33 | $-0.43 | 23.3 % |
Sep 2023 | 2023-11-07 | $-0.39 | $-0.42 | 7.14 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-02-28 | $-110.00K | $30.00K | -466.7 % |
Sep 2022 | 2022-11-10 | $2.00K | $870.00K | -99.8 % |
Jun 2022 | 2022-08-11 | $8.00K | $870.00K | -99.1 % |
Mar 2022 | 2022-05-12 | $32.00K | $1.03M | -96.9 % |
Altimmune (ALT) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.35, which missed the estimate of $-0.34.
The Actual Revenue was $5K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.